###begin article-title 0
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
Quantitative Analysis of SMN1 Gene and Estimation of SMN1 Deletion Carrier Frequency in Korean Population based on Real-Time PCR
###end article-title 0
###begin p 1
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">patients</span>
###xml 770 777 <span type="species:ncbi:9606">persons</span>
Spinal muscular atrophy (SMA) is an autosomal recessive disorder, caused by homozygous absence of the survival motor neuron gene (SMN1) in approximately 94% of patients. Since most carriers have only one SMN1 gene copy, several SMN1 quantitative analyses have been used for the SMA carrier detection. We developed a reliable quantitative real-time PCR with SYBR Green I dye and studied 13 patients with SMA and their 24 parents, as well as 326 healthy normal individuals. The copy number of the SMN1 gene was determined by the comparative threshold cycle (Ct) method and albumin was used as a reference gene. The homozygous SMN1 deletion ratio of patients was 0.00 and the hemizygous SMN1 deletion ratio of parents ranged from 0.39 to 0.59. The DeltaDeltaCt ratios of 7 persons among 326 normal individuals were within the carrier range, 0.41-0.57. According to these data, we estimated the carrier and disease prevalence of SMA at 1/47 and 1/8,496 in Korean population, respectively. These data indicated that there would be no much difference in disease prevalence of SMA compared with western countries. Since the prevalence of SMA is higher than other autosomal recessive disorders, the carrier detection method using real-time PCR could be a useful tool for genetic counseling.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
Spinal muscular atrophy (SMA) is one of the most common autosomal recessive disorders characterized by progressive muscle weakness caused by degeneration of the spinal anterior horn cells. SMA has a prevalence of 1/6,000 to 1/10,000 births and a carrier frequency of 1/40 to 1/50 (1-3). According to age of onset and severity of symptoms, patients with SMA are subdivided into three clinical types (4). Type I (Werdnig-Hoffmann disease; OMIM 253300) is the most severe form with the onset at birth to the first few month and death by 2 yr of life. Type II (OMIM 253550), intermediate form, is characterized by the onset before 18 months of age and survival beyond 4 yr-old age. Type III (Kugelberg-Welander disease; OMIM 253400) is the mildest form with the onset after the age of 2 yr and survival into adulthood.
###end p 3
###begin p 4
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 417 418 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 420 421 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 478 482 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 491 492 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 558 559 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 561 563 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
All types of SMA are associated with homozygous deletion in the survival motor neuron 1 gene (SMN1; OMIM 600354) (5). SMN1 and its homologous gene, SMN2 (OMIM 601627), are located on 5q13. The two SMN genes are different at only five nucleotide exchanges within their 3' ends (5, 6). In contrast to SMN1, the expression of SMN2 protein is truncated from skipping of exon 7 by a single nucleotide exchange (840C-->T) (7, 8). Approximately 94% of SMA patients lack both copies of SMN1 exon 7 (9), which can be detected by the commonly used molecular analyses (2, 10).
###end p 4
###begin p 5
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
As the carrier frequency in population is high, the carrier test for SMA is important issue in genetic counseling. Until now, several quantitative PCR methods for SMN1 analysis have been developed for carrier detection (11-14). However, these methods were intricate and easily submitted to errors. Recently reported quantitative real-time PCR assays (15, 16) allow the specific amplification of only SMN1 gene, and become powerful tools to avoid these problems. However, these tests include still several limitations in relation to the specificity, and cost-effectiveness.
###end p 5
###begin p 6
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 421 429 <span type="species:ncbi:9606">patients</span>
In consideration of these defects, we developed a reliable quantitative real-time PCR method using SMN1 gene specific primers and SYBR Green I dye for the carrier detection of SMA. The comparative Ct (threshold cycle) method was used to quantify the copy numbers of SMN1 gene. This test allowed us to analyze a large number of samples efficiently. Here, we report the results of quantitative analysis of SMN1 gene in SMA patients and parents, and the estimated carrier frequency in Korean population.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Subjects
###end title 8
###begin p 9
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Quantitative analysis of SMN1 gene was done in 13 patients with SMA and their 24 parents. Clinical diagnosis was fulfilled on all patients and homozygous absence of SMN1 exon 7 was confirmed with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) (2, 10).
###end p 9
###begin p 10
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
To estimate the carrier frequency in Korean population, we selected 326 unrelated healthy individuals aged 19-81 yr who participated in a comprehensive health screening in Ansan Health Center (17). Informed consents for DNA analysis were obtained from the patients and normal individuals.
###end p 10
###begin title 11
DNA extraction
###end title 11
###begin p 12
Genomic DNA was extracted from peripheral blood samples by the QIAamp DNA blood kit (Qiagen, Hilden, Germany) and was measured by an Ultrospec(R)2100 (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.). Samples that had purity in the range of 1.5-1.8 (260 nm/280 nm ratio) were used for highly efficient amplification. DNAs were diluted to a final concentration of 2.5 ng/microL.
###end p 12
###begin title 13
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
Quantitative real-time PCR of SMN1
###end title 13
###begin p 14
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 1089 1093 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 1286 1290 1262 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 575 582 <span type="species:ncbi:9606">patient</span>
###xml 658 663 <span type="species:ncbi:9606">human</span>
The quantitative real-time PCR assay was based on primers that specifically amplify SMN1 gene. To distinguish SMN1 from SMN2 (GenBank AH006635) in the amplication reactions, 3' ends of the primers were designed to end on the SMN1 specific sequence in exon 7 at position 6 and intron 7 at position +2: forward primer is 5'-CCTTTTATTTTCCTTACAGGGTTTC-3'; reverse primer is 5'-GATTGTTTTACATTAACCTTTCAACTTTT-3'. Specificity of the SMN1 primers was confirmed by multiplex PCR with COL1A1 gene (forward primer, 5'-GGGGGAACAAGGCTGTCT-3'; reverse primer, 5'-TCCTGGGGTTCAGACCAA-3') in patient samples and a normal individual's. As a reference gene, we used exon 12 of human serum albumin: forward primer is 5'-AGCTATCCGTGGTCCTGAAC-3; reverse primer is 5'-TTCTCAGAAAGTGTGCATATATCTG-3'. Using the ABI PRISM(R)7700 Sequence Detection System (PE Applied Biosystems, Foster City, CA, U.S.A.), the PCR was performed in a total volume of 20 microL in each well, containing 10 microL of SYBR Green(R) PCR Master Mix (PE Applied Biosystems), 20 ng of genomic DNA (8 microL), and 0.1 microM and 0.5 microM of SMN1 and albumin primers, which was determined after the analysis of the optimal concentrations of each primer. Each sample was run in triplicates in separate tubes to permit quantification of the SMN1 gene normalized to albumin. The PCR condition consisted of initial denaturation step of 95℃ for 10 min, followed by 40 cycles of 95℃ for 15 sec and 60℃ for 1 min.
###end p 14
###begin title 15
Data analysis
###end title 15
###begin p 16
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 408 412 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 631 635 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 721 734 693 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
###xml 779 792 735 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
###xml 213 221 <span type="species:ncbi:9606">Patients</span>
###xml 873 881 <span type="species:ncbi:9606">patients</span>
All data were calculated by the comparative Ct method, to detect the relative gene copy numbers (18). By using a calibrator sample of a normal control DNA, the gene copy numbers of unknown samples were estimated. Patients, carrier, and unrelated normal samples were analyzed together with the calibrator sample on every assay plate. DeltaCt represents the mean Ct value of each sample and was calculated for SMN1 and albumin. The gene copy numbers of the samples were determined by the following formula: DeltaDeltaCt=[DeltaCt albumin (calibrator sample)-DeltaCt SMN1 (calibrator sample)]-[DeltaCt albumin (unknown sample)-DeltaCt SMN1 (unknown sample)]. The relative gene copy numbers were calculated by the expression 2-DeltaDeltaCt. Using this method, a DeltaDeltaCt ratio, [2-DeltaDeltaCt], was expected to be about 1 in normal controls, about 0.5 in carriers and 0 in patients with SMA.
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 366 373 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 500 507 500 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1C</xref>
###xml 576 580 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 657 661 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 706 712 698 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 719 725 711 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 811 818 795 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1079 1086 1055 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1224 1228 1200 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 1230 1237 1206 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
###xml 953 960 <span type="species:ncbi:9606">persons</span>
The Ct values of SMN1 and albumin triplicates showed almost identical at the amplification plots of a normal control (Fig. 1A). The standard deviations of triplicate Ct values for all samples were very low (mean, 0.10; range, 0.00-0.32). In parents of SMA patients, carrying only one SMN1 gene copy, the Ct values of SMN1 increased about 1.32 compared with albumin (Fig. 1B). In the SMA patients, the albumin gene was amplified as in normal controls, but the SMN1 gene was not amplified as expected (Fig. 1C). Their DeltaDeltaCt ratios were 0.00 showing homozygous absence of SMN1 gene. In accordance with this result, there were no visible products of the SMN1 genes in SMA patients by multiplex PCR with COL1A1 gene (Fig. 2). The range of measured DeltaDeltaCt ratios in 24 parents was between 0.39 and 0.59 (Table 1). To estimate the frequency of carrier in general population, we tested 326 healthy individuals. Among them, DeltaDeltaCt ratios of 7 persons were within the carrier range, 0.41-0.57, indicating that the carrier prevalence was about 1/47 in Korean population (Table 2). The others were detected between 0.84 and 2.19. This result was classified into three groups according to the expected copy numbers of SMN1 (Table 2).
###end p 18
###begin title 19
DISCUSSION
###end title 19
###begin p 20
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
SMA carrier test based on direct quantitative analysis of SMN1 gene is one of the most important issues, since homozygous deletion of SMN1 exon 7 is a common variant. However, the reports of SMA carrier frequency have been concentrated in western countries (3, 11). Therefore, we tried to calculate the SMA carrier frequency in Korea and developed the reliable quantitative test of SMN1 based on real-time PCR with the SYBR Green I dye using the comparative Ct method. We used primers ending on to the nucleotide exchanges between the SMN1 and SMN2 genes in exon 7 to distinguish the SMN1 and SMN2 genes. The specificity and sensitivity of the test are 100%, although the presence of two SMN1 copies per chromosome or intragenic point mutations in some of the SMA chromosomes (approximately 5%) slightly decreases the sensitivity of the test.
###end p 20
###begin p 21
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 244 252 244 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Tables 1</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 329 333 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 535 536 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 538 539 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 541 543 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 569 573 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 641 643 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 644 646 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
We determined the range of carrier gene dosage in 24 parents (0.39-0.59) of SMA patients, in which homozygous deletion of SMN1 gene were identified previously by PCR-RFLP (Table 1), and then screened 326 healthy normal individuals. As shown in Tables 1 and 2, there is no overlap between the range of DeltaDeltaCt ratio measured SMN1 copy numbers in carriers and normal individuals. The prevalence of carrier was 1/47 in Korean population (95% confidence interval: 1/175-1/27), within the similar ranges reported in western countries (1, 3, 11). In 65 individuals, the SMN1 copy numbers were three or four copies like as in other countries (11-13).
###end p 21
###begin p 22
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
Since SMA is a fatal disease, coefficient of selection of SMN1 deleted homozygotes is almost one. Therefore, extrapolation of Hardy-Weinberg equation to calculate the prevalence of SMN1 deleted homozygotes in a population seems to be unreasonable. Nevertheless, if ignoring this potential bias, the disease prevalence of SMN1 deleted homozygotes calculated by Hardy-Weinberg equation was 1/8,496 in Koreans. The estimated prevalence was also not much different from those of other European countries. Since there was no available information of SMA prevalence in East Asian countries including Korea, estimated prevalence presented in this study would be valuable for pursuing SMA pathogenesis and genetic counseling.
###end p 22
###begin p 23
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
###xml 386 392 <span type="species:ncbi:9606">infant</span>
The SMN2, highly homologous gene of SMN1, is a well-established disease-modifying gene for SMA and has been shown to decrease the severity of type I-III SMA in gene dosage analyses (11, 15, 19). The copy number of SMN2 also correlates with longer survival of individuals affected with type I SMA (15). Thus, the quantitative analysis of SMN2 gene enables it possible to predict that an infant with homozygous deletion of SMN1 develop type I, II or III SMA. Although we did not carry out the assay of SMN2 gene in the present study, our real-time quantitative PCR analysis could produce sufficient results.
###end p 23
###begin p 24
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
In conclusion, we detected SMN1 deletion carriers in a general population and calculated the prevalence as the advantages of real-time PCR with SYBR Green I. With relatively high frequency of SMA compared with other autosomal recessive disorders, the carrier detection method using real-time PCR could be a useful tool for genetic counseling.
###end p 24
###begin article-title 25
Classification of spinal muscular atrophies
###end article-title 25
###begin article-title 26
Gnetic testing and risk assessment for spinal muscular atrophy (SMA)
###end article-title 26
###begin article-title 27
Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counseling
###end article-title 27
###begin article-title 28
Meeting report: International SMA Consortium meeting
###end article-title 28
###begin article-title 29
Identification and characterization of a spinal muscular atrophy-determining gene
###end article-title 29
###begin article-title 30
###xml 34 39 <span type="species:ncbi:9606">human</span>
Structure and organization of the human survival motor neurone (SMN) gene
###end article-title 30
###begin article-title 31
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
###end article-title 31
###begin article-title 32
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2
###end article-title 32
###begin article-title 33
An Update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)
###end article-title 33
###begin article-title 34
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy
###end article-title 34
###begin article-title 35
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Identification of proximal spinal muscular atrophy carriers and patients by analyses of SMNT and SMNC copy number
###end article-title 35
###begin article-title 36
Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension
###end article-title 36
###begin article-title 37
###xml 142 150 <span type="species:ncbi:9606">patients</span>
SMA carrier testing-validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion
###end article-title 37
###begin article-title 38
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 deletions
###end article-title 38
###begin article-title 39
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
###end article-title 39
###begin article-title 40
Determination of SMN1 and SMN2 copy number using TaqMantrade mark, Technology
###end article-title 40
###begin article-title 41
Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels
###end article-title 41
###begin article-title 42
Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies
###end article-title 42
###begin article-title 43
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling
###end article-title 43
###begin p 44
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 121 125 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 151 152 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 171 175 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 209 213 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 239 240 223 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 285 289 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 353 357 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
Real-time amplification plots of triplicate SMN1 and albumin of: (A) healthy normal control (DeltaDeltaCt ratio 1.04, SD SMN1 0.09, SD albumin 0.01); (B) carrier with one SMN1 copy (DeltaDeltaCt ratio 0.5, SD SMN1 0.01, SD albumin 0.14); (C) patients with SMA of homozygous absence of SMN1 (DeltaDeltaCt ratio 0.00, SD albumin 0.14, no amplification of SMN1).
###end p 44
###begin p 45
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 125 132 <span type="species:ncbi:9606">patient</span>
Identification of specificity of SMN1 primers in three SMA families and a normal individual by multiplex PCR with COL1A1. P, patient; F, father; M, Mother.
###end p 45
###begin p 46
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Real-time quantitative analysis of SMN1 gene copy number using a comparative Ct method (DeltaDeltaCt ratio) in patients, carriers, and normal individuals
###end p 46
###begin p 47
SD, standard deviation; CV, coefficient of variation.
###end p 47
###begin p 48
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN1</italic>
SMN1 gene copy numbers in Korean population
###end p 48

